131 related articles for article (PubMed ID: 18535616)
21. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
22. Cytokines in head and neck cancer.
Pries R; Wollenberg B
Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
[TBL] [Abstract][Full Text] [Related]
23. [The observation on treatment effects of local adoptive immunotherapy in 33 cases with head and neck cancer].
Han D; Zhu X; Huang Z
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):454-6. PubMed ID: 10920882
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
Specenier PM; Ciuleanu T; Latz JE; Musib LC; Darstein CL; Vermorken JB
Cancer Chemother Pharmacol; 2009 Jul; 64(2):233-41. PubMed ID: 19011858
[TBL] [Abstract][Full Text] [Related]
27. Outcome prediction after surgery and chemoradiation of head-and-neck squamous cell carcinoma (HNSCC), using baseline perfusion computed tomography (CT) microcirculatory parameters vs. tumor volume.
Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1307; author reply 1307. PubMed ID: 19545798
[No Abstract] [Full Text] [Related]
28. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
Uygun K; Bilici A; Karagol H; Caloglu M; Cicin I; Aksu G; Fayda M; Uzunoglu S
Cancer Chemother Pharmacol; 2009 Aug; 64(3):601-5. PubMed ID: 19123002
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
30. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis.
Ribeiro AM; Bocca AL; Amaral AC; Souza AC; Faccioli LH; Coelho-Castelo AA; Figueiredo F; Silva CL; Felipe MS
Vaccine; 2010 Feb; 28(6):1528-34. PubMed ID: 20045500
[TBL] [Abstract][Full Text] [Related]
31. Novel prophylactic and therapeutic vaccine against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
[TBL] [Abstract][Full Text] [Related]
32. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck.
Harrington KJ; El-Hariry IA; Holford CS; Lusinchi A; Nutting CM; Rosine D; Tanay M; Deutsch E; Matthews J; D'Ambrosio C; Turner SJ; Pandeshwara JS; Bourhis J
J Clin Oncol; 2009 Mar; 27(7):1100-7. PubMed ID: 19171712
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.
Silva CL; Bonato VL; Coelho-Castelo AA; De Souza AO; Santos SA; Lima KM; Faccioli LH; Rodrigues JM
Gene Ther; 2005 Feb; 12(3):281-7. PubMed ID: 15526006
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma.
Fujimoto Y; Mizuno T; Sugiura S; Goshima F; Kohno S; Nakashima T; Nishiyama Y
Acta Otolaryngol; 2006 Oct; 126(10):1115-7. PubMed ID: 16923721
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations.
Smith MC; Zimmerman MB; Burke DK; Bauman NM; Sato Y; Smith RJ;
Laryngoscope; 2009 Jan; 119(1):107-15. PubMed ID: 19117316
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.
Wang SX; Bao A; Herrera SJ; Phillips WT; Goins B; Santoyo C; Miller FR; Otto RA
Clin Cancer Res; 2008 Jun; 14(12):3975-83. PubMed ID: 18559620
[TBL] [Abstract][Full Text] [Related]
39. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival.
Italiano A; Ortholan C; Dassonville O; Poissonnet G; Thariat J; Benezery K; Vallicioni J; Peyrade F; Marcy PY; Bensadoun RJ
Cancer; 2008 Dec; 113(11):3160-8. PubMed ID: 18932260
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia in advanced head and neck squamous cell carcinoma: prevalence and potential impact on palliative care.
Alsirafy SA; Sroor MY; Al-Shahri MZ
J Support Oncol; 2009; 7(5):154-7. PubMed ID: 19831158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
